Glenn Snyder is a principal with Deloitte Consulting LLP. He leads Deloitte's Medical Technology practice. Glenn has been serving the life sciences and healthcare industry as a consultant since 1989 and has been with Deloitte since 1995, tackling issues and opportunities across the healthcare value chain over the course of his career, including the payor and provider sectors.

Glenn's expertise is within strategy for the life sciences sector, with deep experience in medical technology, biotech, and specialty pharmaceuticals. He has helped clients improve net reimbursement, articulate product economic value, launch new products, improve market access and rationalize distribution networks; expand in new/emerging markets; navigate changes in the healthcare ecosystem (including those specific to health reform) by modifying their commercial model; develop tangible growth plans that incorporate maturity aspirations, external pressures, and internal development expectations; and grow through innovation of customer solutions as well as acquisitions.

An eminent speaker and thought leader, Glenn has presented at notable conferences, including AdvaMed, Lifesciences Alley, Medical Device Strategic Pricing, and Analytical and Lifesciences Systems Assoc. He has also published articles and whitepapers through Deloitte University Press and industry journals. His most recent papers / articles include "Mobilizing MedTech for mHealth: Market trends and potential opportunities" (October 2015), "Devices and diseases: How the IoT is transforming MedTech" (September 2015), and "The current and future state of companion diagnostics" (March 2015), among others.

Glenn holds a Master of Business Administration in Finance and Strategic Management from the Wharton School of the University of Pennsylvania, a Master of Science in Engineering from the University of Southern California, and a Bachelor of Science in Engineering from Cal Poly, San Luis Obispo.